Search Results - David T Kent
- Showing 1 - 20 results of 52
- Go to Next Page
-
1
New approaches in gene therapy for sickle cell disease, moving in vivo by David G. Kent
Published in HemaSphere (2024-03-01)Get full text
Article -
2
-
3
Different roles for different bones—Location matters for blood production by David G. Kent
Published in HemaSphere (2024-07-01)Get full text
Article -
4
-
5
The Next Generation of FACS – Not Just a Uniform Blob of Fluorescence by David G. Kent
Published in HemaSphere (2022-04-01)Get full text
Article -
6
-
7
IL‐11—An aging‐related cytokine with opportunities for regulating hematopoiesis by David G. Kent
Published in HemaSphere (2024-11-01)Get full text
Article -
8
Lemonade From Lemons: Recruiting Blood Stem Cells into Action by David G. Kent
Published in HemaSphere (2020-06-01)Get full text
Article -
9
UK Instrumentation & Control Manufacturing Sector by David W Kent
Published in Measurement + Control (2008-03-01)Get full text
Article -
10
-
11
MDS and TP53: When One Hit Just Isn’t Enough… by David G. Kent
Published in HemaSphere (2020-12-01)Get full text
Article -
12
Cytokine Combinations wERKing to a Different Tune by David G. Kent
Published in HemaSphere (2021-08-01)Get full text
Article -
13
LiveSeq: A New Technique to Sample RNA From Cells Without Killing Them by David G. Kent
Published in HemaSphere (2023-03-01)Get full text
Article -
14
-
15
Just a Spoonful of Sugar Helps the HSCs Move ’Round by David G. Kent
Published in HemaSphere (2021-04-01)Get full text
Article -
16
-
17
Response to Collinson et al. Comment by Miriam Belmonte, Nina F. Øbro, David G. Kent
Published in HemaSphere (2020-12-01)Get full text
Article -
18
-
19
391 Value estimation of the Diabetes Prevention Program: How well does clinical trial-based cost-effectiveness apply to the real world? by Natalia Olchanski, Samuel B. Weidner, Joshua T. Cohen, David M. Kent
Published in Journal of Clinical and Translational Science (2024-04-01)Get full text
Article -
20
